Fluidigm’s BioMark HD System is a multi-application genomics and
proteomics platform that provides results equivalent to the gold
standards for every respective experimental approach. The system
produces high-quality data from RNA, miRNA and DNA from sample sizes
down to the single cell level -- and now extends to proteins. The
BioMark HD System performs analysis of protein expression, gene
expression, copy number variation, SNP genotyping, and digital PCR.
Olink Bioscience's Proseek Multiplex is a multivariate protein biomarker detection kit based on Olink’s proprietary Proximity Extension Assay (PEA). It uniquely allows multiplexing of immunoassays without compromising assay performance. PEA uses pairs of oligonucleotide-labeled antibodies equipped with DNA reporter molecules to bind to proteins of interest in a highly specific manner, solving the antibody cross-reactivity dilemma that plagues and limits conventional protein assays.
About Olink Bioscience
Olink Bioscience develops, manufactures, and markets unique and highly innovative proprietary products for biomarker research and development. Together with their customers and collaborators they aim to improve clinical decision making by the use of molecular biomarkers. Their groundbreaking tools gain new insights in disease processes, improve disease detection, and contribute to a better understanding of biology. The Duolink® In Situ product line enables detailed analyses of cell signaling pathways by microscopic visualization and quantification of endogenous protein interactions and modifications. Duolink is today used by a broad customer base worldwide in both academia and pharmaceutical industry with over 700 customer publications. Proseek Multiplex is a next generation multivariate protein biomarker detection kit. It uniquely allows multiplexing of immunoassays without compromising assay performance. Proseek simultaneously quantifies up to 92 proteins in just 1 µL liquid samples, such as serum and plasma, with exceptional analytical performance.
Olink Bioscience is headquartered in Uppsala,
For more information, please visit www.olink.com.
For more information, please visit www.fluidigm.com.
Use of Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to Fluidigm’s product and marketing plans, development, objectives, expectations and/or strategies. Forward-looking statements are subject to numerous risks and uncertainties that could cause actual results to differ materially from currently anticipated results, including challenges inherent in developing, manufacturing, marketing, and selling products. Information on these and additional risks affecting Fluidigm’s business and operating results are contained in its filings with the
Fellow, Corporate Communications and Press Relations
Most Popular Stories
- NSA Defends Global Cellphone Tracking Legality
- Top Websites for U.S. Hispanics
- Ad Counts Rise in 2013 for Hispanic Magazines
- Networks Vie for U.S. Hispanic TV Viewers
- Saab Gets Back into the Game; U.S. Auto Sales Soar
- Apple Activates Customer-Tracking iBeacon
- Dell Offers Undisclosed Number of Employee Buyouts
- 2013 Tech Gift Guide: iPad Mini Still Hot; Chromecast a Great Low-Cost Option
- A Biography of Jonathan Ive, Apple's Creative Chief
- Authorities Close to Deal with JPMorgan Chase over Madoff Response